<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37207203</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Cell membrane-bound toll-like receptor-1/2/4/6 monomers and -2 heterodimer inhibit enterovirus 71 replication by activating the antiviral innate response.</ArticleTitle><Pagination><StartPage>1187035</StartPage><MedlinePgn>1187035</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1187035</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1187035</ELocationID><Abstract><AbstractText>Host immune activation is critical for enterovirus 71 (EV71) clearance and immunopathogenesis. However, the mechanism of innate immune activation, especially of cell membrane-bound toll-like receptors (TLRs), against EV71 remains unknown. We previously demonstrated that TLR2 and its heterodimer inhibit EV71 replication. In this study, we systematically investigated the effects of TLR1/2/4/6 monomers and TLR2 heterodimer (TLR2/TLR1, TLR2/TLR6, and TLR2/TLR4) on EV71 replication and innate immune activation. We found that the overexpression of human- or mouse-derived TLR1/2/4/6 monomers and TLR2 heterodimer significantly inhibited EV71 replication and induced the production of interleukin (IL)-8 via activation of the phosphoinositide 3-kinase/protein kinase B (<i>PI3K/AKT</i>) and mitogen-activated protein kinase (<i>MAPK</i>) pathways. Furthermore,human-mouse chimeric TLR2 heterodimer inhibited EV71 replication and activated innate immunity. Dominant-negative TIR-less (DN)-TLR1/2/4/6 did not exert any inhibitory effects, whereas DN-TLR2 heterodimer inhibited EV71 replication. Prokaryotic expression of purified recombinant EV71 capsid proteins (VP1, VP2, VP3, and VP4) or overexpression of EV71 capsid proteins induced the production of IL-6 and IL-8 via activation of the <i>PI3K/AKT</i> and <i>MAPK</i> pathways. Notably, two types of EV71 capsid proteins served as pathogen-associated molecular patterns for TLR monomers (TLR2 and TLR4) and TLR2 heterodimer (TLR2/TLR1, TLR2/TLR6, and TLR2/TLR4) and activated innate immunity. Collectively, our results revealed that membrane TLRs inhibited EV71 replication via activation of the antiviral innate response, providing insights into the EV71 innate immune activation mechanism.</AbstractText><CopyrightInformation>Copyright Â© 2023 Sun, Li, Su, Ren, Guo, Wang, Du and Xie.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Ping-Ping</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Wen-Ping</ForeName><Initials>WP</Initials><AffiliationInfo><Affiliation>Department of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiang-Li</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Microbiology Laboratory, Chengde Center for Disease Control and Prevention, Chengde, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Luan-Ying</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Guang-Cheng</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Pathogenic Biology, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medicine, College of Basic Medicine, Chengde Medical University, Chengde, Hebei, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051194">Toll-Like Receptor 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051195">Toll-Like Receptor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051216">Toll-Like Receptor 6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051193">Toll-Like Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051194" MajorTopicYN="Y">Toll-Like Receptor 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051195" MajorTopicYN="N">Toll-Like Receptor 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051216" MajorTopicYN="N">Toll-Like Receptor 6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051193" MajorTopicYN="N">Toll-Like Receptors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antiviral innate immunity</Keyword><Keyword MajorTopicYN="N">capsid proteins</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">immune activation</Keyword><Keyword MajorTopicYN="N">toll-like receptors</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>15</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37207203</ArticleId><ArticleId IdType="pmc">PMC10189127</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1187035</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis (1974) 129:304â09. doi:Â 10.1093/infdis/129.3.304</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara A, Tagaya I, Yoneyama T. Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology (1978) 9:60â3. doi:Â 10.1159/000148922</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000148922</ArticleId><ArticleId IdType="pubmed">202573</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G, et al. . Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol (1979) 60:329â40. doi:Â 10.1007/BF01317504</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317504</ArticleId><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, et al. . Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. for the outbreak study group. Clin Infect Dis (2000) 31:678â83. doi:Â 10.1086/314032</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, et al. . An epidemic of enterovirus 71 infection in taiwan. Taiwan enterovirus epidemic working group. N Engl J Med (1999) 341:929â35. doi:Â 10.1056/NEJM199909233411301</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, et al. . An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol (2009) 44:262â67. doi:Â 10.1016/j.jcv.2009.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.02.002</ArticleId><ArticleId IdType="pubmed">19269888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, et al. . An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in fuyang city of China. Virol J (2010) 7:94. doi:Â 10.1186/1743-422X-7-94</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-94</ArticleId><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>De W, Changwen K, Wei L, Monagin C, Jin Y, Cong M, et al. . A large outbreak of hand, foot, and mouth disease caused by EV71 and CAV16 in guangdong, China, 2009. Arch Virol (2011) 156:945â53. doi:Â 10.1007/s00705-011-0929-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-0929-8</ArticleId><ArticleId IdType="pubmed">21305327</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PN, Shih SR. Update on enterovirus 71 infection. Curr Opin Virol (2014) 5:98â104. doi:Â 10.1016/j.coviro.2014.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2014.03.007</ArticleId><ArticleId IdType="pubmed">24727707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinobe R, Wiyatno A, Artika IM, Safari D. Insight into the enterovirus A71: a review. Rev Med Virol (2022) 32:e2361. doi:Â 10.1002/rmv.2361</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2361</ArticleId><ArticleId IdType="pubmed">35510476</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis (2010) 10:778â90. doi:Â 10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J, Shen L, Wu J, Zou X, Gu J, Chen J, et al. . Enterovirus A71 proteins: structure and function. Front Microbiol (2018) 9:286. doi:Â 10.3389/fmicb.2018.00286</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00286</ArticleId><ArticleId IdType="pmc">PMC5826392</ArticleId><ArticleId IdType="pubmed">29515559</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Li Y. Recent progress on functional genomics research of enterovirus 71. Virol Sin (2019) 34:9â21. doi:Â 10.1007/s12250-018-0071-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-018-0071-9</ArticleId><ArticleId IdType="pmc">PMC6420560</ArticleId><ArticleId IdType="pubmed">30552635</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human p-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med (2009) 15:794â97. doi:Â 10.1038/nm.1961</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, et al. . Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med (2009) 15:798â801. doi:Â 10.1038/nm.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka C, Suzuki T, Kotani O, Iwata-Yoshikawa N, Nagata N, Ami Y, et al. . The role of VP1 amino acid residue 145 of enterovirus 71 in viral fitness and pathogenesis in a cynomolgus monkey model. PLoS Pathog (2015) 11:e1005033. doi:Â 10.1371/journal.ppat.1005033</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005033</ArticleId><ArticleId IdType="pmc">PMC4504482</ArticleId><ArticleId IdType="pubmed">26181772</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Qu M, Liu H, Wan X, Li F, Hou A, et al. . Myristoylation of EV71 VP4 is essential for infectivity and interaction with membrane structure. Virol Sin (2020) 35:599â613. doi:Â 10.1007/s12250-020-00226-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00226-1</ArticleId><ArticleId IdType="pmc">PMC7736455</ArticleId><ArticleId IdType="pubmed">32399947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol (2011) 30:16â34. doi:Â 10.3109/08830185.2010.529976</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830185.2010.529976</ArticleId><ArticleId IdType="pubmed">21235323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol (2009) 21:317â37. doi:Â 10.1093/intimm/dxp017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxp017</ArticleId><ArticleId IdType="pmc">PMC2721684</ArticleId><ArticleId IdType="pubmed">19246554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun (2009) 388:621â25. doi:Â 10.1016/j.bbrc.2009.08.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.08.062</ArticleId><ArticleId IdType="pubmed">19686699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lester SN, Li K. Toll-like receptors in antiviral innate immunity. J Mol Biol (2014) 426:1246â64. doi:Â 10.1016/j.jmb.2013.11.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2013.11.024</ArticleId><ArticleId IdType="pmc">PMC3943763</ArticleId><ArticleId IdType="pubmed">24316048</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, Liu L, Wang Y. Viral proteins recognized by different TLRs. J Med Virol (2021) 93:6116â23. doi:Â 10.1002/jmv.27265</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27265</ArticleId><ArticleId IdType="pubmed">34375002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R, Kao L, Lin S, Wang RY, Shih S. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One (2013) 8:e63431. doi:Â 10.1371/journal.pone.0063431</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063431</ArticleId><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi C, Sun Q, Wang S, Zhang Z, Li X, Cardona CJ, et al. . Robust antiviral responses to enterovirus 71 infection in human intestinal epithelial cells. Virus Res (2013) 176:53â60. doi:Â 10.1016/j.virusres.2013.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.05.002</ArticleId><ArticleId IdType="pubmed">23685430</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong X, Zhou J, Zhu W, Liu N, Li J, Li L, et al. . Excessive proinflammatory cytokine and chemokine responses of human monocyte-derived macrophages to enterovirus 71 infection. BMC Infect Dis (2012) 12:224. doi:Â 10.1186/1471-2334-12-224</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-224</ArticleId><ArticleId IdType="pmc">PMC3519709</ArticleId><ArticleId IdType="pubmed">22994237</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Yu CK, Wang JR, Su IJ, Liu CC. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis (2008) 198:1002â06. doi:Â 10.1086/591462</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591462</ArticleId><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, Yang KD. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr (2002) 91:632â35. doi:Â 10.1080/080352502760069016</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/080352502760069016</ArticleId><ArticleId IdType="pubmed">12162592</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu H, Wang L, Yang F, Hu Y, Ren X, et al. . Comparative study of the cytokine/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease. PLoS One (2013) 8:e67430. doi:Â 10.1371/journal.pone.0067430</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067430</ArticleId><ArticleId IdType="pmc">PMC3696071</ArticleId><ArticleId IdType="pubmed">23840697</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Wang Y, Gan X, Song J, Sun P, Dong XP. Serum cytokine profiles of children with human enterovirus 71-associated hand, foot, and mouth disease. J Med Virol (2014) 86:1377â85. doi:Â 10.1002/jmv.23929</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23929</ArticleId><ArticleId IdType="pubmed">24619468</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathinayake PS, Hsu AC, Wark PA. Innate immunity and immune evasion by enterovirus 71. Viruses (2015) 7:6613â30. doi:Â 10.3390/v7122961</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122961</ArticleId><ArticleId IdType="pmc">PMC4690884</ArticleId><ArticleId IdType="pubmed">26694447</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnare M, Rollinghoff M, Qureshi S. Toll-like receptors: sentinels of host defence against bacterial infection. Int Arch Allergy Immunol (2006) 139:75â85. doi:Â 10.1159/000090001</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000090001</ArticleId><ArticleId IdType="pubmed">16319494</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KA, Kagan JC. Toll-like receptors and the control of immunity. Cell (2020) 180:1044â66. doi:Â 10.1016/j.cell.2020.02.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.041</ArticleId><ArticleId IdType="pmc">PMC9358771</ArticleId><ArticleId IdType="pubmed">32164908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Ng MM, Chu JJ. Activation of TLR2 and TLR6 by dengue NS1 protein and its implications in the immunopathogenesis of dengue virus infection. PloS Pathog (2015) 11:e1005053. doi:Â 10.1371/journal.ppat.1005053</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005053</ArticleId><ArticleId IdType="pmc">PMC4520596</ArticleId><ArticleId IdType="pubmed">26226614</ArticleId></ArticleIdList></Reference><Reference><Citation>Henrick BM, Yao XD, Rosenthal KL. HIV-1 structural proteins serve as PAMPs for TLR2 heterodimer significantly increasing infection and innate immune activation. Front Immunol (2015) 6:426. doi:Â 10.3389/fimmu.2015.00426</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00426</ArticleId><ArticleId IdType="pmc">PMC4541371</ArticleId><ArticleId IdType="pubmed">26347747</ArticleId></ArticleIdList></Reference><Reference><Citation>Nazli A, Kafka JK, Ferreira VH, Anipindi V, Mueller K, Osborne BJ, et al. . HIV-1 gp120 induces TLR2- and TLR4-mediated innate immune activation in human female genital epithelium. J Immunol (2013) 191:4246â58. doi:Â 10.4049/jimmunol.1301482</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301482</ArticleId><ArticleId IdType="pubmed">24043886</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshaghdali K, Saeed M, Kamal MA, Saeed A. Interaction of ectodomain of respiratory syncytial virus G protein with TLR2/TLR6 heterodimer: an In vitro and in silico approach to decipher the role of RSV G protein in pro-inflammatory response against the virus. Curr Pharm Des (2021) 27:4464â76. doi:Â 10.2174/1381612827666210716160030</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612827666210716160030</ArticleId><ArticleId IdType="pubmed">34279194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim CU, Jeong YJ, Lee P, Lee MS, Park JH, Kim YS, et al. . Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activating toll-like receptor 4 and the NLRP3 inflammasome. Cell Mol Immunol (2022) 19:715â25. doi:Â 10.1038/s41423-022-00862-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-022-00862-5</ArticleId><ArticleId IdType="pmc">PMC9026019</ArticleId><ArticleId IdType="pubmed">35459853</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanmohammadi S, Rezaei N. Role of toll-like receptors in the pathogenesis of COVID-19. J Med Virol (2021) 93:2735â39. doi:Â 10.1002/jmv.26826</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26826</ArticleId><ArticleId IdType="pmc">PMC8014260</ArticleId><ArticleId IdType="pubmed">33506952</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K, Vakakis E, Richer EA, Evans GL, Villiers JP, Triantafilou M. Human rhinovirus recognition in non-immune cells is mediated by toll-like receptors and MDA-5, which trigger a synergetic pro-inflammatory immune response. Virulence (2011) 2:22â9. doi:Â 10.4161/viru.2.1.13807</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.2.1.13807</ArticleId><ArticleId IdType="pmc">PMC3073236</ArticleId><ArticleId IdType="pubmed">21224721</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Su M, Sun PP, Guo WP, Wang CY, Wang JL, et al. . Global profiling of the alternative splicing landscape reveals transcriptomic diversity during the early phase of enterovirus 71 infection. Virology (2020) 548:213â25. doi:Â 10.1016/j.virol.2020.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2020.06.011</ArticleId><ArticleId IdType="pubmed">32763492</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YC, Zhou Y, Fang H, Lin S, Wang PF, Xiong RP, et al. . Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage. Ann Neurol (2014) 75:876â89. doi:Â 10.1002/ana.24159</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24159</ArticleId><ArticleId IdType="pubmed">24752976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo WT, Lee TC, Yang HY, Chen CY, Au YC, Lu YZ, et al. . LPS receptor subunits have antagonistic roles in epithelial apoptosis and colonic carcinogenesis. Cell Death Differ (2015) 22:1590â604. doi:Â 10.1038/cdd.2014.240</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.240</ArticleId><ArticleId IdType="pmc">PMC4563778</ArticleId><ArticleId IdType="pubmed">25633197</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths MJ, Ooi MH, Wong SC, Mohan A, Podin Y, Perera D, et al. . In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1beta, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis. J Infect Dis (2012) 206:881â92. doi:Â 10.1093/infdis/jis446</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis446</ArticleId><ArticleId IdType="pubmed">22829643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis (2003) 36:269â74. doi:Â 10.1086/345905</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/345905</ArticleId><ArticleId IdType="pubmed">12539066</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, Yu CK, et al. . Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis (2003) 188:564â70. doi:Â 10.1086/376998</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/376998</ArticleId><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Li W, Yang X, Zhang T, Wang Y, Zhong R, et al. . Interleukin-8 is elevated in severe hand, foot, and mouth disease. J Infect Dev Ctries (2014) 8:94â100. doi:Â 10.3855/jidc.3542</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.3542</ArticleId><ArticleId IdType="pubmed">24423718</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Li R, Xie Z, Huang G, Yuan Q, Zeng J. IL-6, IL-10 and IL-13 are associated with pathogenesis in children with enterovirus 71 infection. Int J Clin Exp Med (2014) 7:2718â23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4211780</ArticleId><ArticleId IdType="pubmed">25356130</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui YL, Tan TL, Timms P, Hafner LM, Tan KH, Tan EL. Elucidating the host-pathogen interaction between human colorectal cells and invading enterovirus 71 using transcriptomics profiling. FEBS Open Bio (2014) 4:426â31. doi:Â 10.1016/j.fob.2014.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fob.2014.04.005</ArticleId><ArticleId IdType="pmc">PMC4050184</ArticleId><ArticleId IdType="pubmed">24918057</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Foo DG, Trasti SL, Tan EL, Alonso S. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J Virol (2011) 85:3067â76. doi:Â 10.1128/JVI.01779-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01779-10</ArticleId><ArticleId IdType="pmc">PMC3067852</ArticleId><ArticleId IdType="pubmed">21228224</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Zhang R, Wu W, Duan G. Antiviral and inflammatory cellular signaling associated with enterovirus 71 infection. Viruses (2018) 10:155. doi:Â 10.3390/v10040155</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10040155</ArticleId><ArticleId IdType="pmc">PMC5923449</ArticleId><ArticleId IdType="pubmed">29597291</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M, Khanbabaei H, Teimoori A. An update on enterovirus 71 infection and interferon type I response. Rev Med Virol (2019) 29:e2016. doi:Â 10.1002/rmv.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2016</ArticleId><ArticleId IdType="pmc">PMC7169063</ArticleId><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain SK, Panda S, Sahu BP, Sarangi R. Activation of host cellular signaling and mechanism of enterovirus 71 viral proteins associated with hand, foot and mouth disease. Viruses (2022) 14:2190. doi:Â 10.3390/v14102190</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102190</ArticleId><ArticleId IdType="pmc">PMC9609926</ArticleId><ArticleId IdType="pubmed">36298746</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox JA, Hiscox JA, Solomon T, Ooi MH, Ng L. Immunopathogenesis and virus-host interactions of enterovirus 71 in patients with hand, foot and mouth disease. Front Microbiol (2017) 8:2249. doi:Â 10.3389/fmicb.2017.02249</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02249</ArticleId><ArticleId IdType="pmc">PMC5713468</ArticleId><ArticleId IdType="pubmed">29238324</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Li W, Qi G, Liu N, Sheng L, Shang L, et al. . The immune mechanism of intestinal tract toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway. Exp Ther Med (2017) 13:2263â66. doi:Â 10.3892/etm.2017.4245</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2017.4245</ArticleId><ArticleId IdType="pmc">PMC5443248</ArticleId><ArticleId IdType="pubmed">28565836</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Zhang Y, Wang J, Zhao H, Jiang L, Che Y, et al. . Study of the integrated immune response induced by an inactivated EV71 vaccine. PLoS One (2013) 8:e54451. doi:Â 10.1371/journal.pone.0054451</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0054451</ArticleId><ArticleId IdType="pmc">PMC3553120</ArticleId><ArticleId IdType="pubmed">23372725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Hu YC, Liang CC, Lin SY, Liang YC, Yuan HP, et al. . Enterovirus-71 virus-like particles induce the activation and maturation of human monocyte-derived dendritic cells through TLR4 signaling. PLoS One (2014) 9:e111496. doi:Â 10.1371/journal.pone.0111496</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111496</ArticleId><ArticleId IdType="pmc">PMC4216083</ArticleId><ArticleId IdType="pubmed">25360749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S, Dolganiuc A, Szabo G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis c virus core and NS3 proteins. J Leukoc Biol (2007) 82:479â87. doi:Â 10.1189/jlb.0207128</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0207128</ArticleId><ArticleId IdType="pubmed">17595379</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajalakshmy AR, Malathi J, Madhavan HN. Hepatitis c virus NS3 mediated microglial inflammation via TLR2/TLR6 MyD88/NF-kappaB pathway and toll like receptor ligand treatment furnished immune tolerance. PLoS One (2015) 10:e125419. doi:Â 10.1371/journal.pone.0125419</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0125419</ArticleId><ArticleId IdType="pmc">PMC4428696</ArticleId><ArticleId IdType="pubmed">25965265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y, Mansell A, Ussher JE, Brooks AE, Manning K, Wang CJ, et al. . Rotavirus NSP4 triggers secretion of proinflammatory cytokines from macrophages via toll-like receptor 2. J Virol (2013) 87:11160â67. doi:Â 10.1128/JVI.03099-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03099-12</ArticleId><ArticleId IdType="pmc">PMC3807279</ArticleId><ArticleId IdType="pubmed">23926349</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang JY, Nan X, Jin MS, Youn SJ, Ryu YH, Mah S, et al. . Recognition of lipopeptide patterns by toll-like receptor 2-toll-like receptor 6 heterodimer. Immunity (2009) 31:873â84. doi:Â 10.1016/j.immuni.2009.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.09.018</ArticleId><ArticleId IdType="pubmed">19931471</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, et al. . Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell (2007) 130:1071â82. doi:Â 10.1016/j.cell.2007.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.09.008</ArticleId><ArticleId IdType="pubmed">17889651</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol (2001) 75:10730â37. doi:Â 10.1128/JVI.75.22.10730-10737.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.22.10730-10737.2001</ArticleId><ArticleId IdType="pmc">PMC114654</ArticleId><ArticleId IdType="pubmed">11602714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, et al. . Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 1:398â401. doi:Â 10.1038/80833</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/80833</ArticleId><ArticleId IdType="pubmed">11062499</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao K, Chen M, Jie X, Wang Y, Li Q, Xu J. H5N1 virus hemagglutinin inhibition of cAMP-dependent CFTR via TLR4-mediated janus tyrosine kinase 3 activation exacerbates lung inflammation. Mol Med (2015) 21:134â42. doi:Â 10.2119/molmed.2014.00189</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2014.00189</ArticleId><ArticleId IdType="pmc">PMC4461576</ArticleId><ArticleId IdType="pubmed">25587856</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Lizarbe S, Montesinos J, Guerri C. Ethanol induces TLR4/TLR2 association, triggering an inflammatory response in microglial cells. J Neurochem (2013) 126:261â73. doi:Â 10.1111/jnc.12276</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12276</ArticleId><ArticleId IdType="pubmed">23600947</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z, McMinn P. A single mutation in capsid protein VP1 (Q145E) of a genogroup C4 strain of human enterovirus 71 generates a mouse-virulent phenotype. J Gen Virol (2012) 93:1935â40. doi:Â 10.1099/vir.0.043893-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.043893-0</ArticleId><ArticleId IdType="pubmed">22647370</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZW, Zhuang ZC, Chen R, Wang XR, Zhang HL, Li SH, et al. . Enterovirus 71 VP1 protein regulates viral replication in SH-SY5Y cells via the mTOR autophagy signaling pathway. Viruses (2019) 12:11. doi:Â 10.3390/v12010011</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010011</ArticleId><ArticleId IdType="pmc">PMC7019657</ArticleId><ArticleId IdType="pubmed">31861844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Bai Y, Liu W, Xiao X, Huang Y, Cen S, et al. . Immunization of n terminus of enterovirus 71 VP4 elicits cross-protective antibody responses. BMC Microbiol (2013) 13:287. doi:Â 10.1186/1471-2180-13-287</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-13-287</ArticleId><ArticleId IdType="pmc">PMC4029445</ArticleId><ArticleId IdType="pubmed">24320792</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing J, Zhang A, Du Y, Fang M, Minze LJ, Liu YJ, et al. . Identification of poly(ADP-ribose) polymerase 9 (PARP9) as a noncanonical sensor for RNA virus in dendritic cells. Nat Commun (2021) 12:2681. doi:Â 10.1038/s41467-021-23003-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23003-4</ArticleId><ArticleId IdType="pmc">PMC8113569</ArticleId><ArticleId IdType="pubmed">33976210</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>